Literature DB >> 20473934

Existence of tumor-derived endothelial cells suggests an additional role for endothelial-to-mesenchymal transition in tumor progression.

Laurent Selek, Mehdi Dhobb, Boudewijn van der Sanden, François Berger, Didier Wion.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 20473934     DOI： 10.1002/ijc.25446

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  5 in total

1.  Hypoxia-induced expression of VE-cadherin and filamin B in glioma cell cultures and pseudopalisade structures.

Authors:  Marie-France Nissou; Michèle El Atifi; Audrey Guttin; Catherine Godfraind; Caroline Salon; Emmanuel Garcion; Boudewijn van der Sanden; Jean-Paul Issartel; François Berger; Didier Wion
Journal:  J Neurooncol       Date:  2013-03-31       Impact factor: 4.130

2.  Endothelial Cell-Derived TGF-β Promotes Epithelial-Mesenchymal Transition via CD133 in HBx-Infected Hepatoma Cells.

Authors:  Preety Rawal; Hamda Siddiqui; Mohsin Hassan; Manish Chandra Choudhary; Dinesh M Tripathi; Vikrant Nain; Nirupama Trehanpati; Savneet Kaur
Journal:  Front Oncol       Date:  2019-04-24       Impact factor: 6.244

3.  Discovery of endothelium and mesenchymal properties of primo vessels in the mesentery.

Authors:  An Ping; Su Zhendong; Dai Jingxing; Liu Yaling; Kyung-Hee Bae; Tan Shiyun; Luo Hesheng; Kwang-Sup Soh; Yeon Hee Ryu; Sungchul Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-15       Impact factor: 2.629

Review 4.  Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.

Authors:  Ana Cavaco; Maryam Rezaei; Stephan Niland; Johannes A Eble
Journal:  Int J Mol Sci       Date:  2017-11-07       Impact factor: 5.923

5.  Endothelial‑to‑mesenchymal transition in human idiopathic dilated cardiomyopathy.

Authors:  Yeqing Xie; Jianquan Liao; Yong Yu; Qi Guo; Yingzhen Yang; Junbo Ge; Haozhu Chen; Ruizhen Chen
Journal:  Mol Med Rep       Date:  2017-11-08       Impact factor: 2.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.